72.11.Z - Research and experimental development on biotechnology
62.01.Z - Computer programming activities
62.09.Z - Other information technology and computer service activities
72.19.Z - Other research and experimental development on natural sciences and engineering
77.40.Z - Leasing of intellectual property and similar products, except copyrighted works
2022 | 2023 | ||
---|---|---|---|
K PLN | K PLN | % | |
Gross profit (loss) | 0 | 44,2 | -∞ |
EBITDA | 0 | 44,2 | -∞ |
Short time liabilities | 0 | 4 | -∞ |
Equity capital | 5 | 45,3 | 805,3 |
Operating profit (EBIT) | 0 | 44,2 | -∞ |
Assets | 5 | 49,3 | 885,8 |
Net profit (loss) | 0 | 40,3 | -∞ |
Cash | 5 | 14,5 | 189,8 |
Net income from sale | 0 | 56,6 | -∞ |
Liabilities and provisions for liabilities | 0 | 4 | -∞ |
Working assets | 5 | 49,3 | 885,8 |
Depreciation | 0 | 0 | 0 |
% | % | p.p. | |
Profitability of capital | 0 | 89 | 89 |
Equity capital to total assets | 100 | 91,8 | -8,2 |
Gross profit margin | 78,2 | ||
EBITDA Margin | 78,2 | ||
Days | Days | Days | |
Short term commitment turnover cycle | 0 | 26 | 26 |
Current financial liquidity indicator | 12.245443344116211 | ||
Net dept to EBITDA | -0.3274332582950592 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane